Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Targeted serum metabolomics (CHRIS baseline)
x0pt137
PC ae C36:4
Phosphatidylcholine acyl-alkyl C36:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt136
PC ae C36:3
Phosphatidylcholine acyl-alkyl C36:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt135
PC ae C36:2
Phosphatidylcholine acyl-alkyl C36:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt134
PC ae C36:1
Phosphatidylcholine acyl-alkyl C36:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt133
PC ae C36:0
Phosphatidylcholine acyl-alkyl C36:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt132
PC ae C34:3
Phosphatidylcholine acyl-alkyl C34:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt131
PC ae C34:2
Phosphatidylcholine acyl-alkyl C34:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt130
PC ae C34:1
Phosphatidylcholine acyl-alkyl C34:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt129
PC ae C34:0
Phosphatidylcholine acyl-alkyl C34:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt128
PC ae C32:2
Phosphatidylcholine acyl-alkyl C32:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt127
PC ae C32:1
Phosphatidylcholine acyl-alkyl C32:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt126
PC ae C30:2
Phosphatidylcholine acyl-alkyl C30:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt125
PC ae C30:1
Phosphatidylcholine acyl-alkyl C30:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt124
PC ae C30:0
Phosphatidylcholine acyl-alkyl C30:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt022
Phe
Phenylalanine
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec07
Percentage of interval differences of successive NN intervals greater than 50 ms (pNN50)
Percentage of interval differences of successive NN intervals greater than 50 ms (pNN50)
Float
ECG 10s (CHRIS baseline)
x0ec105d
P-Amplitude positive, aVR
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec105e
P-Amplitude positive, aVL
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec105f
P-Amplitude positive, aVF
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec105l
P-Amplitude positive, V6
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec105k
P-Amplitude positive, V5
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec105j
P-Amplitude positive, V4
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec105i
P-Amplitude positive, V3
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec105h
P-Amplitude positive, V2
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec105g
P-Amplitude positive, V1
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec105c
P-Amplitude positive, III
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec105b
P-Amplitude positive, II
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec105a
P-Amplitude positive, I
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec106d
P-Amplitude negative, aVR
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec106e
P-Amplitude negative, aVL
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec106f
P-Amplitude negative, aVF
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec106l
P-Amplitude negative, V6
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec106k
P-Amplitude negative, V5
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec106j
P-Amplitude negative, V4
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec106i
P-Amplitude negative, V3
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec106h
P-Amplitude negative, V2
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec106g
P-Amplitude negative, V1
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec106c
P-Amplitude negative, III
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec106b
P-Amplitude negative, II
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec106a
P-Amplitude negative, I
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead I
Float
Pain sensitivity (CHRIS baseline)
x0ps21
PSQ total
PSQ-total score
Float
Pain sensitivity (CHRIS baseline)
x0ps24
PSQ-short
PSQ-short score
Float
Pain sensitivity (CHRIS baseline)
x0ps22
PSQ moderate
PSQ-moderate score
Float
Pain sensitivity (CHRIS baseline)
x0ps23
PSQ minor
PSQ-minor score
Float
Heart rate variability (CHRIS baseline)
x0ec213
PNS index
PNS index
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt021
Orn
Ornithine
Float
Complement system (CHRIS baseline)
x0cs03
Lectin pathway: Optical density of sample
Optical density of the sample in the lectin pathway measurement
Float
Complement system (CHRIS baseline)
x0cs01
Classical pathway: Optical density of sample
Optical density of the sample in the classical pathway measurement
Float
Complement system (CHRIS baseline)
x0cs02
Alternative pathway: Optical density of sample
Optical density of the sample in the alternative pathway measurement
Float
Complement system (CHRIS baseline)
x0cs03b
Lectin pathway: Optical density of plate positive control
Optical density of the plate's positive control in the lectin pathway measurement
Float
Complement system (CHRIS baseline)
x0cs01b
Classical pathway: Optical density of plate positive control
Optical density of the plate's positive control in the classical pathway measurement
Float
Complement system (CHRIS baseline)
x0cs02b
Alternative pathway: Optical density of plate positive control
Optical density of the plate's positive control in the alternative pathway measurement
Float
Complement system (CHRIS baseline)
x0cs03a
Lectin pathway: Optical density of plate negative control
Optical density of the plate's negative control in the lectin pathway measurement
Float
Complement system (CHRIS baseline)
x0cs01a
Classical pathway: Optical density of plate negative control
Optical density of the plate's negative control in the classical pathway measurement
Float
Complement system (CHRIS baseline)
x0cs02a
Alternative pathway: Optical density of plate negative control
Optical density of the plate's negative control in the alternative pathway measurement
Float
Smoking (CHRIS baseline)
x0sm44
Smoking: Pipe tobacco (past)
On average of the entire time you smoked, before you stopped or cut down, how much did you smoke? Pipe tobacco in grams/week (in the past)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt069
C8
Octanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt054
C18:1
Octadecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt053
C18
Octadecanoylcarnitine
Float
Heart rate variability (CHRIS baseline)
x0ec210
number of corrected beats (%)
Number of corrected beats, expressed as percentage of the total number of beats
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt070
C9
Nonaylcarnitine
Float
ECG 10s (CHRIS baseline)
x0ec143d
Noise, aVR
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec143e
Noise, aVL
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec143f
Noise, aVF
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec143l
Noise, V6
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec143k
Noise, V5
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec143j
Noise, V4
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec143i
Noise, V3
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec143h
Noise, V2
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec143g
Noise, V1
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec143c
Noise, III
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec143b
Noise, II
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec143a
Noise, I
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead I
Float
Blood measurements (CHRIS baseline)
x0lp50f
Neutrophils (absolute neutrophil count)
Neutrophils (absolute neutrophil count)
Float
Blood measurements (CHRIS baseline)
x0lp50a
Neutrophils (NEUT)
Neutrophils (NEUT)
Float
Neutralizing Antibody (CHRIS COVID-19)
ccna01
Neutralizing antibody ID50 value
Neutralizing antibody ID50 value
Float
Heart rate variability (CHRIS baseline)
x0ec260
logtot power (AR)
Natural logarithm transformed values of total spectrum power, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec243
logtot power (Welch)
Natural logarithm transformed values of total spectrum power, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec257
logVLF power (AR)
Natural logarithm transformed values of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec240
logVLF power (Welch)
Natural logarithm transformed values of VLF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec258
logLF power (AR)
Natural logarithm transformed values of LF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec241
logLF power (Welch)
Natural logarithm transformed values of LF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec259
logHF power (AR)
Natural logarithm transformed values of HF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec242
logHF power (Welch)
Natural logarithm transformed values of HF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Blood measurements (CHRIS baseline)
x0lp50h
Monocytes (absolute monocyte count)
Monocytes (absolute monocyte count)
Float
Blood measurements (CHRIS baseline)
x0lp50c
Monocytes (MONO)
Monocytes (MONO)
Float
Heart rate variability (CHRIS baseline)
x0ec224
min HR
Minimum HR computed using N=5 beat moving average
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt063
C5-M-DC
Methylglutarylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt020
Met-SO
Methioninesulfoxide
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt019
Met
Methionine
Float
ECG 10s (CHRIS baseline)
x0ec124b
Median of RR-Intervals
Median of RR-Intervals (computed over the customed beat series), expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec215
mean RR
Mean value of RR intervals, expressed in milliseconds
Float
ECG 10s (CHRIS baseline)
x0ec124a
Mean of RR-Intervals
Mean of RR-Intervals (computed over the customed beat series), expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec222
mean HR
Mean heart rate, expressed in beats per minute
Float
Blood measurements (CHRIS baseline)
x0lp48
Mean Platelet Volume (MPV)
Mean Platelet Volume (MPV)
Float
Blood measurements (CHRIS baseline)
x0lp43
Mean Corpuscular Volume (MCV)
Mean Corpuscular Volume (MCV)
Float
Blood measurements (CHRIS baseline)
x0lp45
Mean Corpuscular Hemoglobin Concentration (MCHC)
Mean Corpuscular Hemoglobin Concentration (MCHC)
Float
Blood measurements (CHRIS baseline)
x0lp44
Mean Corpuscular Hemoglobin (MCH)
Mean Corpuscular Hemoglobin (MCH)
Float
Heart rate variability (CHRIS baseline)
x0ec225
max HR
Maximum HR computed using N=5 beat moving average
Float
Blood measurements (CHRIS baseline)
x0lp26
Magnesium (Mg)
Magnesium (Mg)
Float
Previous
1
32
33
34
35
36
43
Next